Form D · Other Technology

Feel Therapeutics, Inc.

San Francisco, CA · CIK 0001794558

Offering snapshot reported Apr 30, 2025 · SEC filing

Reported sold: $7.88M
Investors reported: 34
Minimum accepted: $0
First sale: Aug 18, 2020

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$4,281,137 → $7,879,846
Reported investors20 → 34

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Apr 30, 2025	Amendment	$7,879,846	$3,598,709vs Jul 26, 2023	34	SEC filing
Jul 26, 2023	Amendment	$4,281,137	$4,031,137vs Sep 2, 2020	20	SEC filing
Sep 2, 2020	Initial	$250,000	No comparison	1	SEC filing
Nov 27, 2019	Initial	$6,248,742	No comparison	13	SEC filing

Offering details

Securities: Debt, Option to acquire
Exemptions: 06b
Duration over one year: Yes
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-374705

Source: Form D, filed Apr 30, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Georgios Eleftheriou	Director, Executive, Promoter
Irini Fragkiskou	Executive
Vica Manos	Director
Charalampos Tsirmpas	Director, Executive, Promoter

Issuer details

Industry: Other Technology (See others in industry)

Address:

479 Jessie Street
San Francisco, CA, 94103